1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 25228590 | Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma. | 2014 Sep 30 | 1 |